The 2nd Bacteriophage Therapy Summit returns once again to bring together industry, leading academics, regulatory bodies and technology experts to accelerate the clinical development, regulation and approval of bacteriophage products.
As we enter the post-antibiotic era, the re-emergence of phage therapy acts as a potential viable replacement for antibiotics. However, the re-emergence does not come without challenges; large scale production, showing efficacy in the clinical setting and navigating a developing regulatory field are just a few limitations the field is currently facing.
This is your opportunity to join leaders developing the next generation of phage therapy products to discuss the latest case-studies and forge collaborations to unlock the full potential of bacteriophage therapeutics.
PHAGE: Therapy, Applications, and Research is the only peer-reviewed journal dedicated to fundamental bacteriophage research and its applications in medicine, agriculture, aquaculture, veterinary applications, animal production, food safety, and food production. Under the distinct leadership of Editor-in-Chief Martha Clokie, PhD, University of Leicester, United Kingdom, the Journal showcases groundbreaking research, reviews, commentaries, opinion pieces, profiles, and perspectives dedicated to defining the roles of phages in all facets of microbiology and microbial ecology and exploring their potential to manipulate bacterial communities and treat infection.
View this virtual event at Bacteriophage Therapy Summit.